Inversago Pharma
Sabina Bangash has extensive experience in clinical research and management, currently serving as Associate Director and Sponsor Oversight Manager at Inversago Pharma since June 2021. Prior to this role, Sabina worked at ICON Clinical Research from December 2007 to March 2023, where responsibilities included serving as Clinical Research Associate and Senior Clinical Research Associate, contributing to significant advancements in clinical trials.
This person is not in any teams
Inversago Pharma
A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the treatment of Prader-Willi Syndrome, diabetes, obesity and other metabolic disorders such as non-alcoholic steatohepatitis (NASH).